Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Open, 2-arm National Multi-center Study to Evaluate the Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation.

NCT00568477 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT00568477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00568477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Open, 2-arm National Multi-center Study to Evaluate the Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation.
Lead sponsor
Technical University of Munich
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2007
Completion date
December 31, 2010
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic allograft nephropathy, grafting, renal transplantation, transplantation, kidney